Skip to main content
Top

International Journal of Hematology

Issue 4/2011

Including PIH Articles on Fanconi Anemia and Mechanisms of the DNA Damage Response

Content (27 Articles)

Editorial

New IJH guidelines highlight greater transparency

Douglas Sipp, Toshio Suda

Images in Hematology

A highly positive nonspecific esterase reaction in a t(15;17)(q22;q12) acute promyelocytic leukemia

Tomohiro Aoki, Takahiro Nishiyama, Nobuhiko Imahashi, Kunio Kitamura

Progress in Hematology

Fanconi anemia: a disorder defective in the DNA damage response

Hiroyuki Kitao, Minoru Takata

Progress in Hematology

Maintenance of genomic integrity in hematopoietic stem cells

Kazuhito Naka, Atsushi Hirao

Progress in Hematology

Fanconi anaemia proteins are associated with sister chromatid bridging in mitosis

Songmin Ying, Ian D. Hickson

Original Article

Early electrocardiographic evaluation of atrial fibrillation risk in beta-thalassemia major patients

Vincenzo Russo, Anna Rago, Bruno Pannone, Federica Di Meo, Andrea Antonio Papa, Maria Carolina Mayer, Anna Spasiano, Maria Giovanna Russo, Paolo Golino, Raffaele Calabrò, Gerardo Nigro

Original Article

Hemostatic changes before and during electrophysiologic study and radiofrequency catheter ablation

Petr Parizek, L. Haman, M. Pleskot, M. Pecka, J. Bukac, P. Stransky, J. Maly

Original Article

Vitamin B12 deficiency, hyperhomocysteinemia and thrombosis: a case and control study

Angel F. Remacha, Joan Carles Souto, José Luis Piñana, María Pilar Sardà, Josep Maria Queraltó, Joan Martí-Fabregas, Xavier García-Moll, Cristina Férnandez, Alvaro Rodriguez, Jorge Cuesta

Original Article

Identification of copy number alterations by array comparative genomic hybridization in patients with late chronic or accelerated phase chronic myeloid leukemia treated with imatinib mesylate

Veera S. Nadarajan, Chin-Lee Phan, Chow-Hiang Ang, Kai-Ling Liang, Gin-Gin Gan, Ping-Chong Bee, Zubaidah Zakaria

Original Article

Analysis of efficacy and cost-effectiveness of high-dose arabinoside versus daunorubicin chemotherapy in older adult patients with acute myeloid leukemia by cytogenetic risk profile: retrospective review from China

Bin-Tao Huang, Yu Wang, Qing-Feng Du, Jun Yang, Jessica Yu, Qing-Chun Zeng, Na Xu, Jin-Fang Zhang, Lu-Lu Xu, Xu-Jing Luo, Yong-Qiang Wei, Xiao-Li Liu

Original Article

Elevated β-arrestin1 expression correlated with risk stratification in acute lymphoblastic leukemia

Hui Liu, Juan Long, Peng-hui Zhang, Kang Li, Jun-jie Tan, Bin Sun, Jie Yu, Zhi-guang Tu, Lin Zou

Original Article

High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma

Dai Chihara, Yasuhiro Oki, Hiroshi Onoda, Hirofumi Taji, Kazuhito Yamamoto, Tsuneo Tamaki, Yasuo Morishima

Original Article

Reduced-intensity conditioning by fludarabine/busulfan without additional irradiation or T-cell depletion leads to low non-relapse mortality in unrelated bone marrow transplantation

Takahiko Nakane, Hirohisa Nakamae, Hideo Koh, Mika Nakamae, Yoshiki Hayashi, Mitsutaka Nishimoto, Takuro Yoshimura, Eri Inoue, Atsushi Inoue, Ran Aimoto, Mizuki Aimoto, Yoshiki Terada, Ki-Ryang Koh, Takahisa Yamane, Masayuki Hino

Original Article

Mortality and medical morbidity beyond 2 years after allogeneic hematopoietic stem cell transplantation: experience at a single institution

W. Munakata, T. Sawada, T. Kobayashi, K. Kakihana, T. Yamashita, K. Ohashi, Y. Onozawa, H. Sakamaki, H. Akiyama

Original Article

Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan

Minako Iida, Takahiro Fukuda, Kazuhiro Ikegame, Satoshi Yoshihara, Hiroyasu Ogawa, Shuichi Taniguchi, Akiyoshi Takami, Yasunobu Abe, Masayuki Hino, Tetsuya Etou, Yasunori Ueda, Toshiaki Yujiri, Toshimitsu Matsui, Atsuo Okamura, Junji Tanaka, Yoshiko Atsuta, Yoshihisa Kodera, Ritsuro Suzuki

Original Article

Clinical significance of subcategory and severity of chronic graft-versus-host disease evaluated by National Institutes of Health consensus criteria

Takayuki Sato, Tatsuo Ichinohe, Junya Kanda, Kouhei Yamashita, Tadakazu Kondo, Takayuki Ishikawa, Takashi Uchiyama, Akifumi Takaori-Kondo

Case Report

A novel mutation of the erythropoietin receptor gene associated with primary familial and congenital polycythaemia

Kacey O’Rourke, David J. Fairbairn, Kathryn A. Jackson, Kirk L. Morris, Siok-Keen Tey, Glen A. Kennedy

Case Report

Radioguided lymph node biopsy of a chemoresistant lymph node detected on interim FDG PET-CT in Hodgkin lymphoma

Tamás Györke, Attila Kollár, Gyula Bottlik, Ágota Szepesi, Imre Bodó, Tamás Masszi, Viktor Bérczi, Ildikó Garai

Case Report

Successful treatment with combined chemotherapy of two adult cases of hemophagocytic lymphohistiocytosis in recipients of umbilical cord blood cell transplantation

Akiko Fukunaga, Fumiaki Nakamura, Noriyoshi Yoshinaga, Shojiro Inano, Wataru Maruyama, Hirokazu Hirata, Nobuyoshi Arima

Letter to the Editor

Successful immunosuppressive and iron chelation therapy for a severe aplastic anemia patient undergoing hemodialysis due to chronic renal failure

Junji Hiraga, Reona Sakemura, Hiroshi Yamashita, Toshimitsu Suzuki, Satoshi Kitagawa, Yasunari Takakuwa, Shinichi Mizuno

Letter to the Editor

Direct antiglobulin test-negative autoimmune hemolytic anemia associated with HLA-haploidentical stem cell transplantation

Jun Nakata, Hiroya Tamaki, Kazuhiro Ikegame, Ruri Kato, Satoshi Yoshihara, Katsuji Kaida, Takayuki Inoue, Toyomi Kamesaki, Masaya Okada, Hiroyasu Ogawa

Letter to the Editor

Donor cell leukemia after umbilical cord blood transplantation: recurrent or de novo? The importance of diagnosis for therapeutic decision making

Yusuke Shono, Mizuha Kosugi-Kanaya, Souichi Shiratori, Junichi Sugita, Katsuya Fujimoto, Takeshi Kondo, Mitsufumi Nishio, Junji Tanaka, Masahiro Imamura

Letter to the Editor

Successful cord blood transplantation in a 42-day-old boy with infantile Krabbe disease

Hiroshi Yagasaki, Maiko Kato, Mika Ishige, Hiroyuki Shichino, Motoaki Chin, Hideo Mugishima

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine